Urgent Acquisition of Isatuximab - 2026 - ULSLO, EPE
About This Opportunity
TranslatedThis tender concerns the urgent acquisition of Isatuximab, a critical pharmaceutical product, for the year 2026. The procuring entity is ULSLO, EPE, an organization likely involved in public health services or hospital management. The specific nature of Isatuximab suggests a focus on specialized medical treatments, potentially for oncological or immunological conditions. The urgency indicated in the title implies a time-sensitive need, possibly due to stock depletion, increased patient demand, or the initiation of new treatment protocols.
The tender, identified by the reference number 111008426, is expected to outline detailed specifications for the Isatuximab product, including dosage forms, packaging requirements, quality standards (such as GMP compliance), and delivery timelines. Bidders will likely need to demonstrate their capacity to supply the required quantities reliably and within the stipulated timeframe. Furthermore, compliance with all relevant national and international pharmaceutical regulations will be a prerequisite.
ULSLO, EPE will be seeking proposals that offer the best value, considering not only the price but also the quality, reliability of supply, and adherence to delivery schedules. The tender process is designed to ensure that essential medical supplies are procured efficiently and transparently, meeting the healthcare needs of the population served by ULSLO, EPE. Further details regarding the bidding process, submission deadlines, and evaluation criteria will be provided in the full tender documentation.
This is a supplies contract in the health and medical services, trade and industry and general supplies sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 23,273.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis urgent tender, issued by ULSLO, EPE in Portugal, seeks the procurement of Isatuximab for the year 2026. ULSLO, EPE is a public entity operating within the Portuguese healthcare sector, and this acquisition is critical to ensuring the continuity of essential medical treatments. The tender falls under the category of pharmaceutical supplies, specifically for a targeted therapeutic agent.
Prospective bidders are invited to submit proposals for the supply of Isatuximab, a monoclonal antibody used in the treatment of certain hematological malignancies. The contracting authority is looking for reliable and experienced suppliers capable of meeting the urgent demand outlined for the specified period. Typical requirements for such tenders include demonstrating robust quality control processes, adherence to stringent regulatory standards for pharmaceutical products, and the capacity to ensure timely and secure delivery. Bidders will likely need to provide detailed product specifications, certifications, and evidence of their manufacturing and distribution capabilities. Furthermore, proposals may be evaluated based on price, delivery timelines, and the supplier's overall ability to meet the specified urgent requirements of ULSLO, EPE.
This procurement is managed through Portugal's public procurement portal, BASE.
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 4, 2026. Last refreshed 12 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Lisboa Ocidental, E. P. E.
Unidade Local de Saúde de Lisboa Ocidental, E. P. E. has issued 731 procurement notices on BidsFactory, including 1 currently open and 642 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
What is the estimated budget?
The estimated contract value is Up to €23,273. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to SANOFI - AVENTIS - PRODUTOS FARMACÊUTICOS, S. A.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Lisboa Ocidental, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.